![Kannan Rangaramanujam](https://kyruus-app-static.kyruus.com/providermatch/johnshopkins/photos/orig/rangaramanujam-kannan.jpg?1738260935390)
Kannan Rangaramanujam, PhD
- Johns Hopkins School of Medicine Faculty
Languages
- English
Gender
MaleAbout Kannan Rangaramanujam
Professional Titles
- Co-Director, Center for Nanomedicine
Primary Academic Title
Professor of Ophthalmology
Background
Kannan Rangaramanujam, Ph.D., is a professor of ophthalmology and co-director of the Center for Nanomedicine at the Wilmer Eye Institute at Johns Hopkins School of Medicine. His research spans a wide range of nanomaterial applications, including nanomedicine and nanocomposites. He has initiated an interdisciplinary translational research program based on dendrimers, with a specific focus on targeted drug delivery for ocular and neurodegenerative diseases such as cerebral palsy and age-related macular degeneration. Dr. Rangaramanujam is an author of four patents and more than 80 peer-reviewed publications. He has won several recognitions, including the National Science Foundation CAREER and Unilever awards, and serves on the editorial board of Nanomedicine.
Dr. Rangaramanujam received his Ph.D. in chemical engineering from the California Institute of Technology and completed a postdoctoral fellowship at the University of Minnesota. After two years as a senior research engineer at 3M Corporate Research, he joined the faculty of Wayne State University in Detroit, Michigan as a professor of chemical engineering, materials science and biomedical engineering. He joined the Hopkins faculty in 2011.
Centers and Institutes
Recent News Articles and Media Coverage
In Mice, Johns Hopkins Researchers Find the Cause of and Cure for Brain Injury Associated With Gut Condition in Preemies. Hopkins Newsroom (Dec 2018)
Additional Academic Titles
Professor of Pharmacology and Molecular Sciences
Contact for Research Inquiries
400 N. Broadway
Smith Building 6023
Baltimore, MD 21287
Phone: (443) 287-7921
krangar1@jhmi.edu
Research Interests
Drug delivery for ocular and neurodegenerative diseases, Nanomedicine
Additional Training
University of Minnesota, Minneapolis, Minnesota, 1995, Chemical Engineering